stage iiic prostate cancer ajcc v8

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C

Active, not recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Spectroscopic Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +22 more
  • TRPV6 Calcium Channel Inhibitor SOR-C13
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Houston

Recruiting
  • Stage I Prostate Cancer AJCC v8
  • +8 more
  • Counseling
  • +4 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Cancer Survivor, Partner, Spouse Trial in Houston (Exercise Intervention, Informational Intervention, Interview)

Recruiting
  • Cancer Survivor
  • +11 more
  • Exercise Intervention
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 23, 2022

s Among African American Stage 0-III Prostate Cancer Survivors

Recruiting
  • Cancer Survivor
  • +11 more
  • Accelerometer
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 21, 2022

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022